Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy

Despite passing the pandemic phase of the COVID-19, researchers are still investigating various drugs. Previous evidence suggests that blocking the calcium channels may be a suitable treatment option. Ca(2+) is required to enhance the fusion process of Severe acute respiratory syndrome coronavirus 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Fani, Mona, Moossavi, Maryam, Bakhshi, Hasan, Jahrodi, Abozar Nasiri, Khazdair, Mohammad Reza, Zardast, Amir Hossein, Ghafari, Shokouh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2023
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494978/
https://www.ncbi.nlm.nih.gov/pubmed/37700758
http://dx.doi.org/10.2217/fvl-2022-0203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494978/
https://www.ncbi.nlm.nih.gov/pubmed/37700758
http://dx.doi.org/10.2217/fvl-2022-0203

Ejemplares similares